ASH-话题@MedSci

#ASH#

242篇内容 | 2145人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1301146, encodeId=63581301146c0, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：儿童ALL的基因组分析研究, objectType=article, longId=44391, objectId=86cd44391d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86cd44391d8, replyNumber=0, likeNumber=58, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86cd44391d8, moduleTitle=ASH 2014：儿童ALL的基因组分析研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86cd44391d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301147, encodeId=0d7a130114e25, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：癌症治疗价格日益攀升的伦理问题, objectType=article, longId=44392, objectId=fc604439244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc604439244, replyNumber=0, likeNumber=82, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc604439244, moduleTitle=ASH 2014：癌症治疗价格日益攀升的伦理问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc604439244)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301148, encodeId=c1111301148fb, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：HSCT后单纯性持续性血小板减少症机制, objectType=article, longId=44410, objectId=34934441051, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34934441051, replyNumber=0, likeNumber=75, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34934441051, moduleTitle=ASH 2014：HSCT后单纯性持续性血小板减少症机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34934441051)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301149, encodeId=25fd1301149b8, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：osaroxin+阿糖胞苷改善复发性AML患者的生存, objectType=article, longId=44411, objectId=22bb4441135, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22bb4441135, replyNumber=0, likeNumber=69, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22bb4441135, moduleTitle=ASH 2014：osaroxin+阿糖胞苷改善复发性AML患者的生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22bb4441135)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301150, encodeId=b1eb1301150f2, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：对比亭扎肝素和华法林治疗急性静脉血栓栓塞肿瘤患者的疗效与安全性, objectType=article, longId=44412, objectId=f2cd44412f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2cd44412f2, replyNumber=0, likeNumber=76, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2cd44412f2, moduleTitle=ASH 2014：对比亭扎肝素和华法林治疗急性静脉血栓栓塞肿瘤患者的疗效与安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2cd44412f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301151, encodeId=060f130115144, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：中高危MDS和CMML的临床难题仍待探索, objectType=article, longId=44413, objectId=7a2c44413b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a2c44413b4, replyNumber=0, likeNumber=60, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a2c44413b4, moduleTitle=ASH 2014：中高危MDS和CMML的临床难题仍待探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a2c44413b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301152, encodeId=00ab130115296, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：游离循环DNA测序可检测HL患者的基因失衡, objectType=article, longId=44414, objectId=1781444140b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1781444140b, replyNumber=0, likeNumber=70, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1781444140b, moduleTitle=ASH 2014：游离循环DNA测序可检测HL患者的基因失衡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1781444140b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301153, encodeId=282013011532b, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：Imbruvica使携带del17p突变的CLL患者获益, objectType=article, longId=44418, objectId=20e5444189c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20e5444189c, replyNumber=0, likeNumber=85, createdTime=2014-12-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20e5444189c, moduleTitle=ASH 2014：Imbruvica使携带del17p突变的CLL患者获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20e5444189c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301130, encodeId=3d151301130e0, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2011：迄今为止很大样本研究证实骨髓/外周造血干细胞捐赠是安全的, objectType=article, longId=44225, objectId=c5244422538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5244422538, replyNumber=0, likeNumber=66, createdTime=2014-12-19, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5244422538, moduleTitle=ASH 2011：迄今为止很大样本研究证实骨髓/外周造血干细胞捐赠是安全的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5244422538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301129, encodeId=e9151301129dd, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：聚焦飞速前行的“癌症免疫疗法”, objectType=article, longId=44165, objectId=b8a2441654c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8a2441654c, replyNumber=0, likeNumber=59, createdTime=2014-12-18, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8a2441654c, moduleTitle=ASH 2014：聚焦飞速前行的“癌症免疫疗法”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8a2441654c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301128, encodeId=63fe130112859, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：强生血癌药物Imbruvica在高风险CLL群体表现出强大治疗利益, objectType=article, longId=43996, objectId=e4c04399608, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4c04399608, replyNumber=0, likeNumber=80, createdTime=2014-12-14, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4c04399608, moduleTitle=ASH 2014：强生血癌药物Imbruvica在高风险CLL群体表现出强大治疗利益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4c04399608)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301126, encodeId=58cf1301126f9, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：武田ixazomib单药维持疗法有效改善多发性骨髓瘤（MM）缓解深度, objectType=article, longId=43835, objectId=55fa43835bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55fa43835bc, replyNumber=0, likeNumber=59, createdTime=2014-12-12, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55fa43835bc, moduleTitle=ASH 2014：武田ixazomib单药维持疗法有效改善多发性骨髓瘤（MM）缓解深度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55fa43835bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301127, encodeId=4fb1130112ea1, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：新基公布Revlimid关键III期FIRST研究深度分析数据, objectType=article, longId=43838, objectId=0a924383800, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a924383800, replyNumber=0, likeNumber=50, createdTime=2014-12-12, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a924383800, moduleTitle=ASH 2014：新基公布Revlimid关键III期FIRST研究深度分析数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a924383800)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301123, encodeId=f59b130112346, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：idelalisib用于复发性CLL的长期随访数据正在完善, objectType=article, longId=43827, objectId=a89e4382ea5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a89e4382ea5, replyNumber=0, likeNumber=59, createdTime=2014-12-12, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a89e4382ea5, moduleTitle=ASH 2014：idelalisib用于复发性CLL的长期随访数据正在完善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a89e4382ea5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301124, encodeId=92041301124b3, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：武田抗体偶联药物Adcetris大幅改善复发性系统间变大细胞淋巴瘤（sALCL）生存率, objectType=article, longId=43829, objectId=5fdc43829c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fdc43829c8, replyNumber=0, likeNumber=76, createdTime=2014-12-12, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fdc43829c8, moduleTitle=ASH 2014：武田抗体偶联药物Adcetris大幅改善复发性系统间变大细胞淋巴瘤（sALCL）生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fdc43829c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301125, encodeId=014f130112509, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：诺华filgrastim生物仿制药疗效媲美安进Neupogen, objectType=article, longId=43830, objectId=89874383047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89874383047, replyNumber=0, likeNumber=59, createdTime=2014-12-12, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89874383047, moduleTitle=ASH 2014：诺华filgrastim生物仿制药疗效媲美安进Neupogen, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89874383047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301122, encodeId=3a1813011227f, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：安进BiTE免疫疗法Blincyto有效治疗急性淋巴细胞白血病（ALL）, objectType=article, longId=43800, objectId=5ccf43800e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ccf43800e2, replyNumber=0, likeNumber=66, createdTime=2014-12-11, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ccf43800e2, moduleTitle=ASH 2014：安进BiTE免疫疗法Blincyto有效治疗急性淋巴细胞白血病（ALL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ccf43800e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301121, encodeId=56cb130112158, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=JASH：肾交感神经消融治疗难治性高血压无效原因分析, objectType=article, longId=37677, objectId=b0073e6770f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0073e6770f, replyNumber=0, likeNumber=79, createdTime=2014-07-12, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0073e6770f, moduleTitle=JASH：肾交感神经消融治疗难治性高血压无效原因分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0073e6770f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301120, encodeId=8a03130112040, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=JASH：肾交感神经消融治疗难治性高血压无效原因分析, objectType=article, longId=37672, objectId=fdb73e672e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdb73e672e3, replyNumber=0, likeNumber=72, createdTime=2014-07-12, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdb73e672e3, moduleTitle=JASH：肾交感神经消融治疗难治性高血压无效原因分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdb73e672e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301119, encodeId=f808130111990, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2014：ZS-9对伴高钾血症CKD患者尿钾和尿钠的影响, objectType=article, longId=35124, objectId=310a35124e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=310a35124e9, replyNumber=0, likeNumber=81, createdTime=2014-05-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=310a35124e9, moduleTitle=ASH 2014：ZS-9对伴高钾血症CKD患者尿钾和尿钠的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=310a35124e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASH

2020-05-29

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：儿童ALL的基因组分析研究

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：癌症治疗价格日益攀升的伦理问题

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：HSCT后单纯性持续性血小板减少症机制

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：osaroxin+阿糖胞苷改善复发性AML患者的生存

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：对比亭扎肝素和华法林治疗急性静脉血栓栓塞肿瘤患者的疗效与安全性

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：中高危MDS和CMML的临床难题仍待探索

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：游离循环DNA测序可检测HL患者的基因失衡

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：Imbruvica使携带del17p突变的CLL患者获益

2014-12-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2011：迄今为止很大样本研究证实骨髓/外周造血干细胞捐赠是安全的

2014-12-19

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：聚焦飞速前行的“癌症免疫疗法”

2014-12-18

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：强生血癌药物Imbruvica在高风险CLL群体表现出强大治疗利益

2014-12-14

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：武田ixazomib单药维持疗法有效改善多发性骨髓瘤（MM）缓解深度

2014-12-12

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：新基公布Revlimid关键III期FIRST研究深度分析数据

2014-12-12

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：idelalisib用于复发性CLL的长期随访数据正在完善

2014-12-12

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：武田抗体偶联药物Adcetris大幅改善复发性系统间变大细胞淋巴瘤（sALCL）生存率

2014-12-12

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：诺华filgrastim生物仿制药疗效媲美安进Neupogen

2014-12-12

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：安进BiTE免疫疗法Blincyto有效治疗急性淋巴细胞白血病（ALL）

2014-12-11

kksonne (审核中...)

前往app查看评论内容

#ASH#

JASH：肾交感神经消融治疗难治性高血压无效原因分析

2014-07-12

kksonne (审核中...)

前往app查看评论内容

#ASH#

JASH：肾交感神经消融治疗难治性高血压无效原因分析

2014-07-12

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2014：ZS-9对伴高钾血症CKD患者尿钾和尿钠的影响

2014-05-24

科室
- - 订阅+
  - 更多科室
工具
服务